BridgeMD
Compares treatment options for Analgesia
Official title Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block
ClinicalTrials.gov ID: NCT06636578
What this study is testing
What is dexmedetomidine?
dexmedetomidine is an investigational medicine, being studied as a potential treatment for analgesia.
Also referred to as precedex.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In 2012 Blanco et al. [1] described the ultrasound technique for Pectoral nerve (PECS) block as a new, less invasive regional analgesic technique for breast surgeries.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Age 20 - 65 years,
- Ejection fraction (EF) \> 35%,
- Elective isolated CABG, or Valve surgery
You likely can't join if
- Poor left ventricular function with intra-aortic balloon pump support,
- Recent myocardial infarction (last seven days),
- Combined procedure (i.e., CABG + other heart/vascular procedure),
- Emergency surgery, or Redo cases,
- Hepatic or renal failure, creatinine \>1.5,
- Patients with hemodynamic instability, preexisting infection at the site of block, allergy to local anesthetics, psychiatric illness, and patients...
The study team makes the final eligibility decision.
Where it's taking place
- Al Fayyum, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Fayyum, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.